| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $88M | ||
| $82M |
Buys | $ | – | |
Sells | $ | – |
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.
Over the last 12 months, insiders at Athira Pharma, Inc. have bought $undefined and sold $undefined worth of Athira Pharma, Inc. stock.
On average, over the past 5 years, insiders at Athira Pharma, Inc. have bought $1.03M and sold $50,439 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 27,400 shares for transaction amount of $66,179 was made by Romano Kelly A (director) on 2024‑06‑24.
| Increased Positions | 0 | 0% | 0 | 0% |
| Decreased Positions | 0 | 0% | 0 | 0% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 0 | 0% | 0 | 0% |
| Perceptive Advisors Llc | $3,760.00 | 13.51% | 540,296 | 0 | 0% | 2025-09-30 |
| Bml Capital Management, Llc | $2,249.00 | 8.08% | 323,066 | <1 | 0% | 2025-09-30 |
| Vanguard Group Inc | $1,070.00 | 3.85% | 153,789 | -2 | <0.01% | 2025-09-30 |
| Propel Bio Management, Llc | $1,039.00 | 3.73% | 149,279 | 0 | 0% | 2025-09-30 |
| Simplify Asset Management Inc. | $1,039.00 | 3.73% | 149,279 | 0 | 0% | 2025-09-30 |
| Tang Capital Management Llc | $418.00 | 1.5% | 59,998 | -2 | <0.01% | 2025-09-30 |
| Renaissance Technologies Llc | $361.00 | 1.3% | 51,924 | +27,824 | +115.45% | 2025-09-30 |
| Acadian Asset Management Llc | $280.00 | 1.01% | 40,186 | -362 | -0.89% | 2025-09-30 |
| Pathstone Holdings, Llc | $269.00 | 0.97% | 38,606 | +1,386 | +3.72% | 2025-09-30 |
| Blackrock, Inc. | $262.00 | 0.94% | 37,643 | -2 | <0.01% | 2025-09-30 |